Group 1: Future Growth Points - The company's future growth will be driven by innovation, with key growth points including the increased application of minimally invasive surgery and the widespread use of surgical power devices and disposable consumables [2] - New product lines such as endoscopes and energy surgical equipment will contribute to revenue growth [2] - Expansion into new departments like general surgery, gynecology, and urology will enhance business opportunities [2] - Further development of international market operations is planned [2] Group 2: Marketing System Changes - The marketing system for new product lines remains largely unchanged, focusing on the strategic positioning as a "provider of overall solutions for minimally invasive surgery" [2] - Initial product line layouts target departments with business advantages, including neurosurgery, otolaryngology, and orthopedics [2] Group 3: Use of Raised Funds - The company will strictly adhere to regulations regarding the use of raised funds and is considering how to maximize their value [2] - Future decisions on fund allocation will be made cautiously, taking into account industry trends, overall strategic layout, and actual project conditions [2] Group 4: Investment and Acquisition Plans - The company maintains its strategic positioning as a "provider of overall solutions for minimally invasive surgical tools" and does not rule out pursuing industrial investments to advance the development of the industry chain when suitable targets are available [3]
西山科技(688576) - 重庆西山科技股份有限公司2023年11月21-24日投资者关系活动记录表